Aceso Life Science Group Limited
HKEX:0474.HK
0.06 (HKD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 271 | 312 | 315 | 346 | 295.645 | 319.513 | 330.017 | 206.313 | 129.986 | 60.899 | 40.323 | 112.513 | 143.079 | 122.099 | 97.029 | 166.505 | 176.803 | 156.508 | 151.055 | 130.581 |
| Cost of Revenue
| 132 | 171 | 153 | 133 | 129.048 | 166.174 | 184.291 | 36.725 | 0 | 0 | 0 | 90.405 | 106.358 | 103.072 | 85.641 | 128.56 | 121.171 | 98.775 | 93.29 | 74.76 |
| Gross Profit
| 139 | 141 | 162 | 213 | 166.597 | 153.339 | 145.726 | 169.588 | 129.986 | 60.899 | 40.323 | 22.108 | 36.721 | 19.027 | 11.388 | 37.945 | 55.632 | 57.733 | 57.765 | 55.821 |
| Gross Profit Ratio
| 0.513 | 0.452 | 0.514 | 0.616 | 0.564 | 0.48 | 0.442 | 0.822 | 1 | 1 | 1 | 0.196 | 0.257 | 0.156 | 0.117 | 0.228 | 0.315 | 0.369 | 0.382 | 0.427 |
| Reseach & Development Expenses
| 0 | -0 | -0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 124 | 123 | 146 | 155 | 188.524 | 219.488 | 226.642 | 132.854 | 89.284 | 75.433 | 78.486 | 79.673 | 74.196 | 77.992 | 28.293 | 28.622 | 29.981 | 30.466 | 30.979 | 23.203 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.319 | 3.53 | 4.194 | 2.347 | 3.708 | 4.226 | 0 | 0 | 0 |
| SG&A
| 124 | 123 | 146 | 155 | 188.524 | 219.488 | 226.642 | 132.854 | 89.284 | 75.433 | 78.486 | 81.992 | 77.726 | 82.186 | 30.64 | 32.33 | 34.207 | 30.466 | 30.979 | 23.203 |
| Other Expenses
| 53 | 69 | 35 | 59 | -187.555 | 5.134 | 4.983 | 0.474 | -464.864 | 7.219 | 7.038 | -19.332 | -0.304 | -0.672 | -12.512 | -0.451 | 6.239 | 0 | 4.29 | 3.826 |
| Operating Expenses
| 151 | 125 | 152 | 197 | 188.408 | 215.086 | 214.602 | 162.105 | 89.284 | 75.433 | 78.486 | 86.588 | 96.853 | 90.049 | 18.128 | 39.416 | 40.446 | 30.466 | 35.269 | 27.029 |
| Operating Income
| -241 | -153 | 10 | 16 | -21.811 | -61.747 | -68.876 | 7.483 | 40.702 | -14.534 | -38.163 | -64.48 | -60.132 | -71.022 | -6.74 | -1.471 | 15.186 | 27.267 | 22.496 | 28.792 |
| Operating Income Ratio
| -0.889 | -0.49 | 0.032 | 0.046 | -0.074 | -0.193 | -0.209 | 0.036 | 0.313 | -0.239 | -0.946 | -0.573 | -0.42 | -0.582 | -0.069 | -0.009 | 0.086 | 0.174 | 0.149 | 0.22 |
| Total Other Income Expenses Net
| -257 | -213 | -555 | -323 | -267 | -480.577 | -469.515 | -3,694.224 | 682.141 | 1,860.725 | -68.446 | -68.812 | -294.606 | -25.587 | -461.284 | -19.869 | 11.763 | 7.063 | 8.758 | 6.008 |
| Income Before Tax
| -498 | -213 | -555 | -323 | -267.228 | -480.577 | -538.391 | -3,686.741 | 722.843 | 1,846.191 | -106.609 | -133.292 | -354.738 | -96.609 | -468.024 | -21.34 | 26.949 | 34.33 | 31.254 | 34.8 |
| Income Before Tax Ratio
| -1.838 | -0.683 | -1.762 | -0.934 | -0.904 | -1.504 | -1.631 | -17.87 | 5.561 | 30.316 | -2.644 | -1.185 | -2.479 | -0.791 | -4.824 | -0.128 | 0.152 | 0.219 | 0.207 | 0.267 |
| Income Tax Expense
| -14 | -5 | 41 | 25 | 10.515 | -63.941 | -12.621 | -497.893 | 256.869 | 323.813 | 0.256 | 2.203 | 4.012 | 0.037 | 1.385 | 1.531 | 4.769 | 6.279 | 4.45 | 4.615 |
| Net Income
| -462 | -264 | -370 | -376 | -283.718 | -380.871 | -444.906 | -3,078.901 | 524.398 | 1,522.565 | -12.415 | -219.324 | -378.458 | -96.646 | -469.409 | -22.871 | 22.18 | 28.051 | 26.804 | 30.185 |
| Net Income Ratio
| -1.705 | -0.846 | -1.175 | -1.087 | -0.96 | -1.192 | -1.348 | -14.923 | 4.034 | 25.001 | -0.308 | -1.949 | -2.645 | -0.792 | -4.838 | -0.137 | 0.125 | 0.179 | 0.177 | 0.231 |
| EPS
| -0.064 | -0.036 | -0.051 | -0.057 | -0.049 | -0.077 | -0.091 | -0.64 | 0.13 | 0.53 | -0.006 | -0.28 | -0.65 | -0.24 | -3.73 | -0.28 | 0.27 | 0.35 | 0.34 | 0.38 |
| EPS Diluted
| -0.064 | -0.036 | -0.05 | -0.054 | -0.049 | -0.077 | -0.091 | -0.64 | 0.13 | 0.53 | -0.006 | -0.28 | -0.65 | -0.18 | -3.73 | -0.28 | 0.27 | 0.35 | 0.34 | 0.38 |
| EBITDA
| -220 | -101 | 154 | 473 | -41.813 | 63.17 | -305.892 | 4.038 | -430.102 | -25.658 | -20.258 | -75.052 | -297.082 | -61.273 | -4.831 | -0.272 | 16.906 | 28.666 | 24.776 | 31.18 |
| EBITDA Ratio
| -0.812 | -0.324 | 0.489 | 1.367 | -0.141 | 0.198 | -0.927 | 0.02 | -3.309 | -0.421 | -0.502 | -0.667 | -2.076 | -0.502 | -0.05 | -0.002 | 0.096 | 0.183 | 0.164 | 0.239 |